ITGAM and neoplasm: Globally, data generated in different tumor types and using different RT regimens indicate that high doses (10–30 Gy)—either as single dose or oligo-fractioned (≤3×)—trigger recruitment of CD11b+ myeloid cells and reprogramming of macrophages toward the tumor-promoting M2-phenotype (126, 127).